Literature DB >> 27258196

Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.

Wen-Wen Yue1, Shuo Wang1,2, Hui-Xiong Xu1,3, Li-Ping Sun1, Le-Hang Guo1, Xiao-Wan Bo1, Xiao-Long Li1, Chong-Ke Zhao1, Dan Wang1, Bo-Ji Liu1.   

Abstract

AIM: To evaluate the diagnostic performance of parametric imaging with contrast-enhanced ultrasound(CEUS) for differentiating hepatocellular carcinoma(HCC) from metastatic liver cancer(MLC).
METHODS: 30 HCCs (mean diameter, 3.6±1.3 cm; range, 2.1-5.0 cm) and 30 MLCs (mean diameter, 2.8±1.5 cm; range, 1.2-5.0 cm) pathologically diagnosed or confirmed by clinical criteria that underwent CEUS were randomly included. CEUS was carried out using a multifrequency transducer (2-4 MHz) and a bolus injection of 2.4 mL SonoVue. The CEUS clips of the targeted lesion were recorded continuously for 6 minutes. By analyzing CEUS clips, parametric image could be obtained using the SonoLiver® software automatically. Quantitative parameters were compared between HCC and MLC groups. Receiver operating characteristic (ROC) curve analysis was further performed on parameters with significant difference between two groups.
RESULTS: On parametric imaging, the maximum intensity, rise time, time to peak, mean transit time and washout time for HCC and MLC were 185.6±148.0 vs. 95.2±58.6 (P = 0.003), 25.7±6.3 s vs. 23.8±8.8 s (P = 0.341), 30.7±7.9 s vs. 27.8±10.5 s (P = 0.246), 90.2±45.7 s vs. 89.3±40.3 s (P = 0.805), 63.4±29.5 s vs. 37.2±33.8 s (P = 0.005), respectively. ROC analysis was further performed for washout time and it showed a cut-off point of 43.765 s for the differentiation between HCC and MLC, with the AUC value of 0.780 (95% CI: 0.646-0.914). The corresponding diagnostic specificity, sensitivity and accuracy were 72.0%, 84.6% and 78.4% respectively.
CONCLUSIONS: Parametric imaging of CEUS can display perfusion effects of HCC and MLC objectively and visually and washout time may serve as a useful parameter on the differential diagnosis between HCC and MLC.

Entities:  

Keywords:  Contrast-enhanced ultrasound; hepatocellular carcinoma; metastatic liver cancer; parametric imaging; perfusion parameter

Mesh:

Substances:

Year:  2016        PMID: 27258196     DOI: 10.3233/CH-162060

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  8 in total

1.  Paediatric focal nodular hyperplasia: A case study of typical contrast-enhanced ultrasound findings with quantitative analysis and correlated with magnetic resonance imaging.

Authors:  Andreas Panayiotou; Vasileios Rafailidis; Annamaria Deganello; Maria Sellars; Paul S Sidhu
Journal:  Ultrasound       Date:  2020-08-09

2.  Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.

Authors:  Juanjuan Zhang; Yanyan Yu; Ying Li; Lunshou Wei
Journal:  Oncotarget       Date:  2017-08-07

3.  Impact of contrast ultrasound diagnosis for patients with liver cancer.

Authors:  Hong-Bin Guo; Jun-Hu Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Automatic Respiratory Gating Hepatic DCEUS-based Dual-phase Multi-parametric Functional Perfusion Imaging using a Derivative Principal Component Analysis.

Authors:  Diya Wang; Guy Cloutier; Yan Fan; Yanli Hou; Zhe Su; Qiang Su; Mingxi Wan
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

5.  Characteristics of hepatic solitary necrotic nodules on contrast-enhanced ultrasonography.

Authors:  Chunyu Lu; Shaoshan Tang; Xiaoyue Zhang; Yang Wang; Kaiming Wang; Peng Shen
Journal:  BMC Gastroenterol       Date:  2021-01-25       Impact factor: 3.067

6.  Relationship between quantitative contrast-enhanced ultrasonography parameters and angiogenesis in primary small hepatocellular carcinoma: A retrospective study.

Authors:  Shuhao Deng; Quan Jiang; Yongbing Wang; Xin Lu; Yuan Zhang
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.889

Review 7.  Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound.

Authors:  Junghoan Park; Jeong Min Lee; Tae-Hyung Kim; Jeong Hee Yoon
Journal:  Clin Mol Hepatol       Date:  2021-12-27

8.  Role of Contrast-Enhanced Ultrasonography in Hepatocellular Carcinoma by Using LI-RADS and Ancillary Features: A Single Tertiary Centre Experience.

Authors:  Adriana Ciocalteu; Sevastita Iordache; Sergiu Marian Cazacu; Cristiana Marinela Urhut; Sarmis Marian Sandulescu; Ana-Maria Ciurea; Adrian Saftoiu; Larisa Daniela Sandulescu
Journal:  Diagnostics (Basel)       Date:  2021-11-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.